Physical activity: not measured · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Training intensity: fInal training session (% baseline peak work capacity) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Physiological outcomes: isoload blood lactate (mmol/L) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
QoL · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium showed no clear difference in quality of life (SGRQ) Scale 0 to 100, where 100 represents worst… compared with placebo (high certainty).
1 finding from 1 review
Quality of life: number of participants with clinically significant improvement (≥ 4 units) in SGRQ total score · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium leads to higher number of patients with a clinically significant improvement (≥ 4… compared with placebo (high certainty).
1 finding from 1 review
Number of patients with a clinically significant worsening (≥ 4 units) in quality of life (SGRQ) · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium leads to lower number of patients with a clinically significant worsening (≥ 4… compared with placebo (high certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium leads to lower number of patients with one or more exacerbations compared with placebo (high certainty).
1 finding from 1 review
Hospital admissions due to exacerbations: number of participants · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium showed no clear difference in number of patients with one or more exacerbations requiring… compared with placebo (moderate certainty).
1 finding from 1 review
Hospital admissions · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium showed no clear difference in number of patients with one or more hospitalisations for any cause compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with COPD who have smoked for ≥ 10 pack‐years
Tiotropium showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Linear growth velocity in first year of treatment (cm/y) · children up to 18 years of age with persistent asthma
1 finding from 1 review
Intervention not reported
Change from baseline in height over first year of treatment (cm) · children up to 18 years of age with persistent asthma
1 finding from 1 review
Intervention not reported
Change in height standard deviation score (SDS) in first year of treatment · children up to 18 years of age with persistent asthma
1 finding from 1 review
Intervention not reported
Growth velocity over 12 months (cm/y) (higher is better) · children with persistent asthma
The intervention leads to higher growth velocity over 12 months (cm/y) (higher is better) (high certainty).
1 finding from 1 review
Intervention not reported
Change in height over 3 months (cm) (higher is better) · children with persistent asthma
The intervention showed no clear difference in change in height over 3 months (cm) (higher is better) (moderate certainty).
1 finding from 1 review
Intervention not reported
Change in height over 12 months (cm) (higher is better) · children with persistent asthma
The intervention showed no clear difference in change in height over 12 months (cm) (higher is better) (moderate certainty).
1 finding from 1 review
Intervention not reported
Change in SD scores over 12 months (height) (low change is better) · children with persistent asthma
The intervention showed no clear difference in change in SD scores over 12 months (height) (low change is better) (moderate certainty).
1 finding from 1 review
Intervention not reported
Change in weight over 12 months (kg) (higher is better) · children with persistent asthma
The intervention showed no clear difference in change in weight over 12 months (kg) (higher is better) (low certainty).
1 finding from 1 review
Intervention not reported
Change in BMI over 12 months (kg/m2) (higher is better) · children with persistent asthma
The intervention showed no clear difference in change in BMI over 12 months (kg/m2) (higher is better) (low certainty).
1 finding from 1 review
Intervention not reported
Change in skeletal maturation over 12 months (years) (higher is better) · children with persistent asthma
The intervention may leads to higher change in skeletal maturation over 12 months (years) (higher is… (low certainty).
1 finding from 1 review